Latest Legal Proceedings News

Pacific Current Group reported a net loss for the half-year ending December 2025, driven by significant non-cash impairments and disposals, while repaying its senior secured debt and declaring a fully franked interim dividend.

BPH Energy and Bounty Oil & Gas have concluded their Federal Court hearing challenging the refusal to extend the PEP 11 permit, with the court's decision now pending.

Novatti Group has been served a writ in Malaysia over disputed earn-out payments from its 2022 ATX acquisition, with a claim of approximately AUD 2.67 million. Despite the legal challenge, ATX’s financial performance remains on an upward trajectory.

Energy Resources of Australia reported a significantly reduced net loss of $50 million for 2025, driven by rehabilitation provision adjustments and higher interest income. Meanwhile, rehabilitation delays and Rio Tinto’s compulsory acquisition efforts highlight ongoing operational and ownership challenges.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Peet Limited has reported a robust half-year performance with statutory profit doubling and a significant dividend increase, underpinned by strong sales and settlements across key Australian markets.

Transurban Group posted robust half-year results for December 2025, with revenue climbing 8.1% and profit rebounding to $343 million. The company also declared a 34-cent interim distribution, underpinned by strong cash flow and key project milestones.

Medibank Private Limited reported a 6% rise in operating profit for the half-year ended December 2025, despite an 11% drop in net profit after tax amid ongoing cybercrime-related costs and legal challenges. The company also raised its interim dividend by 6.4%, signalling confidence in its capital position and growth strategy.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

Mayne Pharma has initiated legal proceedings against Cosette Pharmaceuticals and associated parties, seeking substantial damages following the collapse of their acquisition deal.

JB Hi-Fi has reported a solid 7.3% increase in revenue and a 7.1% rise in net profit for the half-year ended December 2025, alongside a fully franked interim dividend of 210 cents per share.

Fiducian Group’s FY2026 half-year results reveal robust growth with a 9% rise in funds under management and a 17% jump in underlying net profit, despite ongoing regulatory challenges.